Synektik had PLN 16.75 mln in net profit and 24.61 mln in EBITDA in Q3 ‘23/’24
12:46
In Q3 2023/2024, Synektik achieved a consolidated net profit of PLN 16.75 million, up from PLN 13.52 million a year ago. Operating profit was PLN 20.67 million, and EBITDA reached PLN 24.61 million. Total revenues were PLN 123.98 million. Over the first nine months of 2023/2024, the company reported a net profit of PLN 63.65 million, with revenues of PLN 482.98 million and EBITDA of PLN 94.52 million.
The medical equipment and IT solutions segment saw a 21% revenue increase, while the radiopharmaceutical segment grew by 21%. Key growth areas included recurring revenues from long-term contracts and the development of robotic surgery. The company signed new distribution agreements and plans to expand its advanced therapeutic equipment offerings.
